Cite
HARVARD Citation
Akazawa, T. et al. (2018). Development of a vaccine based on bacteria‐mimicking tumor cells coated with novel engineered toll‐like receptor 2 ligands. Cancer science. 109 (5), pp. 1319-1329. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Akazawa, T. et al. (2018). Development of a vaccine based on bacteria‐mimicking tumor cells coated with novel engineered toll‐like receptor 2 ligands. Cancer science. 109 (5), pp. 1319-1329. [Online].